1. Home
  2. ATLO vs MDWD Comparison

ATLO vs MDWD Comparison

Compare ATLO & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$27.35

Market Cap

205.2M

Sector

Finance

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$17.63

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
MDWD
Founded
1903
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.2M
224.6M
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
ATLO
MDWD
Price
$27.35
$17.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
36.1K
75.3K
Earning Date
04-24-2026
01-01-0001
Dividend Yield
2.93%
N/A
EPS Growth
8.03
N/A
EPS
0.38
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.97
Revenue Next Year
N/A
$23.59
P/E Ratio
$71.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.09
$14.14
52 Week High
$28.35
$22.51

Technical Indicators

Market Signals
Indicator
ATLO
MDWD
Relative Strength Index (RSI) 58.07 50.59
Support Level $19.47 $16.71
Resistance Level $28.33 $18.58
Average True Range (ATR) 0.65 0.56
MACD -0.22 0.01
Stochastic Oscillator 47.22 53.30

Price Performance

Historical Comparison
ATLO
MDWD

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: